TPD52 Polyclonal Antibody
BS-6742R
ApplicationsImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin
Product group Antibodies
TargetTPD52
Overview
- SupplierBioss
- Product NameTPD52 Polyclonal Antibody
- Delivery Days Customer16
- ApplicationsImmunoFluorescence, Western Blot, ELISA, ImmunoCytoChemistry, ImmunoHistoChemistry, ImmunoHistoChemistry Frozen, ImmunoHistoChemistry Paraffin
- Applications SupplierWB(1:300-5000), ELISA(1:500-1000), IHC-P(1:200-400), IHC-F(1:100-500), IF(IHC-P)(1:50-200), IF(IHC-F)(1:50-200), IF(ICC)(1:50-200)
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration1 ug/ul
- ConjugateUnconjugated
- Gene ID7163
- Target nameTPD52
- Target descriptiontumor protein D52
- Target synonymsD52, N8L, PC-1, PrLZ, hD52, tumor protein D52, prostate and colon associated protein, prostate leucine zipper, protein N8
- HostRabbit
- IsotypeIgG
- Protein IDP55327
- Protein NameTumor protein D52
- Storage Instruction-20°C
- UNSPSC12352203
References
- Wang Y, Chen CL, Pan QZ, et al. Decreased TPD52 expression is associated with poor prognosis in primary hepatocellular carcinoma. Oncotarget. 2016,7(5):6323-34. doi: 10.18632/oncotarget.6319Read this paper




